http://orcid.org/0000-0002-5372-7727
About the Authors
- Beth Buchanan
-
Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
- Qingfang Meng
-
Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – review & editing
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
- Mathieu-Marc Poulin
-
Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Visualization, Writing – review & editing
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
- Jonathan Zuccolo
-
Roles Data curation, Formal analysis, Investigation, Methodology, Validation, Writing – review & editing
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
- Chike Godwin Azike
-
Roles Methodology, Writing – review & editing
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
- Joseph Gabriele
-
Roles Conceptualization, Funding acquisition, Project administration, Supervision, Writing – review & editing
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
- David Charles Baranowski
-
Roles Conceptualization, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Supervision, Writing – review & editing
* E-mail: dbaranowski@delivrainc.com
Affiliation Research and Development, Delivra Corp., Charlottetown, Prince Edward Island, Canada
Competing Interests
The authors are/were employees of Delivra Corp. which has a pending patent on the formulation of topical berberine and dihydroberberine. Patent name: Transdermal Formulations For Delivery Of Berberine Compounds, And Their Use In The Treatment Of Berberine-responsive Diseases And Conditions and number: WO 2017/027971 A1. There are no further patents, products in development or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.